2019 was a male or break year where they went back and spent on enhancing their product which appears to have worked as they are winning teams hand over fist.
- Forums
- ASX - By Stock
- CAT
- Ann: FY19 Results Presentation
Ann: FY19 Results Presentation, page-57
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.89 |
Change
-0.080(4.06%) |
Mkt cap ! $504.8M |
Open | High | Low | Value | Volume |
$1.95 | $1.95 | $1.89 | $545.0K | 282.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 12960 | $1.89 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.90 | 17002 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2022 | 1.915 |
1 | 1350 | 1.910 |
2 | 1742 | 1.905 |
8 | 19633 | 1.900 |
1 | 1350 | 1.895 |
Price($) | Vol. | No. |
---|---|---|
1.920 | 6586 | 6 |
1.925 | 1246 | 1 |
1.930 | 22652 | 4 |
1.935 | 8769 | 2 |
1.940 | 6425 | 4 |
Last trade - 11.21am 16/07/2024 (20 minute delay) ? |
Featured News
CAT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online